Analyst Price Target is $87.33
▲ +53.72% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for NovoCure in the last 3 months. The average price target is $87.33, with a high forecast of $130.00 and a low forecast of $50.00. The average price target represents a 53.72% upside from the last price of $56.82.
Current Consensus is
The current consensus among 6 polled investment analysts is to hold stock in NovoCure. This rating has held steady since June 2022, when it changed from a Buy consensus rating.